All Stories

  1. Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)

    Article • British Journal of Clinical Pharmacology, October 2014, Wiley

    Dr DJ Murry

  2. Critical Illness Is a Major Determinant of Midazolam Clearance in Children Aged 1 Month to 17 Years

    Article • Therapeutic Drug Monitoring, August 2012, Wolters Kluwer Health

    Dr DJ Murry

  3. Drug Testing in the Workplace

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, May 2012, Wiley

    Dr DJ Murry

  4. Permeation and Systemic Absorption of R- and S-Baclofen Across the Nasal Mucosa

    Article • Journal of Pharmaceutical Sciences, July 2011, Elsevier

    Dr DJ Murry

  5. Combination of dexamethasone, high-dose cytarabine, and carboplatin is effective for advanced large-cell non-Hodgkin lymphoma of childhood

    Article • Cancer, August 2008, Wiley

    Dr DJ Murry

  6. Role of xenobiotic efflux transporters in resistance to vincristine

    Article • Biomedicine & Pharmacotherapy, February 2008, Elsevier

    Dr DJ Murry

  7. Development and validation of a liquid chromatography–mass spectrometry assay for the determination of pyronaridine in human blood for application to clinical pharmacokinetic studies

    Article • Journal of Pharmaceutical and Biomedical Analysis, September 2007, Elsevier

    Dr DJ Murry

  8. Development and validation of a liquid chromatography–mass spectrometry assay for the determination of pyronaridine in human urine

    Article • Journal of Chromatography B, June 2007, Elsevier

    Dr DJ Murry

  9. Lovastatin specifically prevents focal ischemic ventricular tachycardia due to triggered activity

    Article • Heart Rhythm, May 2007, Elsevier

    Dr DJ Murry

  10. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer

    Article • Lung Cancer, December 2006, Elsevier

    Dr DJ Murry

  11. Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia

    Article • Cancer Chemotherapy and Pharmacology, November 2006, Springer Science + Business Media

    Dr DJ Murry

  12. Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

    Article • Investigational New Drugs, September 2006, Springer Science + Business Media

    Dr DJ Murry

  13. Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies

    Article • Cancer Chemotherapy and Pharmacology, September 2006, Springer Science + Business Media

    Dr DJ Murry

  14. Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines

    Article • Biochemical Pharmacology, June 2006, Elsevier

    Dr DJ Murry

  15. A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors

    Article • Cancer Chemotherapy and Pharmacology, May 2006, Springer Science + Business Media

    Dr DJ Murry

  16. Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy

    Article • Journal of Pharmaceutical and Biomedical Analysis, May 2006, Elsevier

    Dr DJ Murry

  17. Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies

    Article • Cancer Chemotherapy and Pharmacology, August 2005, Springer Science + Business Media

    Dr DJ Murry

  18. Determination of Salvinorin A in body fluids by high performance liquid chromatography–atmospheric pressure chemical ionization

    Article • Journal of Chromatography B, April 2005, Elsevier

    Dr DJ Murry

  19. Development and validation of a high-performance liquid chromatography–mass spectroscopy assay for determination of artesunate and dihydroartemisinin in human plasma

    Article • Journal of Chromatography B, February 2005, Elsevier

    Dr DJ Murry

  20. A Facile Method for the Preparation of Deuterium Labeled Salvinorin A: Synthesis of [2,2,2-2H3]-Salvinorin A.

    Article • ChemInform, January 2005, Wiley

    Dr DJ Murry

  21. Pharmacokinetics of the plant-derived κ-opioid hallucinogen salvinorin A in nonhuman primates

    Article • Synapse, January 2005, Wiley

    Dr DJ Murry

  22. A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A

    Article • Bioorganic & Medicinal Chemistry Letters, October 2004, Elsevier

    Dr DJ Murry

  23. Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer

    Article • Investigational New Drugs, August 2004, Springer Science + Business Media

    Dr DJ Murry

  24. Light induces phenylpropanoid metabolism inArabidopsisroots

    Article • The Plant Journal, June 2004, Wiley

    Dr DJ Murry

  25. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs

    Article • Journal of the American Veterinary Medical Association, February 2004, American Veterinary Medical Association (AVMA)

    Dr DJ Murry

  26. Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer

    Article • Cancer Chemotherapy and Pharmacology, November 2003, Springer Science + Business Media

    Dr DJ Murry

  27. Influence of Phenytoin on the Disposition of Irinotecan: A Case Report

    Article • February 2002, Wolters Kluwer Health

    Dr DJ Murry

  28. Determination of albumin and myoglobin in dialysate and ultrafiltrate samples by high-performance size-exclusion chromatography

    Article • Journal of Chromatography B Biomedical Sciences and Applications, April 2001, Elsevier

    Dr DJ Murry

  29. Clinical Pharmacology of Encapsulated Sustained-Release Cytarabine

    Article • Annals of Pharmacotherapy, October 2000, SAGE Publications

    Dr DJ Murry

  30. Clinical Pharmacology of Encapsulated Sustained-Release Cytarabine

    Article • Annals of Pharmacotherapy, October 2000, SAGE Publications

    Dr DJ Murry

  31. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates

    Article • Cancer Chemotherapy and Pharmacology, March 1999, Springer Science + Business Media

    Dr DJ Murry

  32. Pharmacokinetics of Ibuprofen in Patients with Cystic Fibrosis

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, March 1999, Wiley

    Dr DJ Murry

  33. Pharmacokinetics and Cerebrospinal Fluid Penetration of Daunorubicin, Idarubicin, and Their Metabolites in the Nonhuman Primate Model

    Article • Journal of Pediatric Hematology/Oncology, January 1999, Wolters Kluwer Health

    Dr DJ Murry

  34. Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primates

    Article • Cancer Chemotherapy and Pharmacology, March 1998, Springer Science + Business Media

    Dr DJ Murry

  35. Impact of nutrition on pharmacokinetics of anti‐neoplastic agents

    Article • International Journal of Cancer, January 1998, Wiley

    Dr DJ Murry

  36. Impact of nutrition on pharmacokinetics of anti-neoplastic agents

    Article • International Journal of Cancer, January 1998, Wiley

    Dr DJ Murry

  37. SIMPLIFIED METHODS FOR DETERMINING GLOMERULAR FILTRATION RATE (GFR) USING PLASMA CLEARANCE (PC) OF IOHEXOL OR 99mTc-DTPA (DTPA) † 1664

    Article • Pediatric Research, April 1997, Springer Science + Business Media

    Dr DJ Murry

  38. Carboplatin pharmacokinetics in young children with brain tumors

    Article • Cancer Chemotherapy and Pharmacology, August 1996, Springer Science + Business Media

    Dr DJ Murry

  39. Ifosfamide-induced hyperpigmentation

    Article • Cancer, January 1994, Wiley

    Dr DJ Murry

  40. Pharmacokinetics and acute renal effects of continuously infused carboplatin

    Article • Clinical Pharmacology & Therapeutics, October 1993, Springer Science + Business Media

    Dr DJ Murry

  41. Ifosfamide-induced hyperpigmentation

    Article • Cancer, May 1993, Wiley

    Dr DJ Murry